日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis

不可切除肝细胞癌一线替雷利珠单抗联合乐伐替尼治疗的临床结果:一项回顾性分析

Lin, Jizong; Zhou, Qingxun; Yao, Zhicheng; Wang, Qingliang; Xu, Shilei; Xiong, Zhiyong; Dang, Xi; Liang, Hao; Liu, Bo

Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4(+) T cells through regulating type 2 conventional dendritic cells

阻断 Tim-3 可通过调节 2 型常规树突状细胞来释放 CD4(+) T 细胞,从而增强 STING 激动剂 ADU-S100 的抗肿瘤免疫作用。

Luo, Jing; Pang, Shuju; Hui, Zhenzhen; Zhao, Hua; Xu, Shilei; Yu, Wenwen; Yang, Lili; Sun, Qian; Hao, Xishan; Wei, Feng; Wang, Jian; Ren, Xiubao

Identification of a novel four-gene diagnostic signature for patients with sepsis by integrating weighted gene co-expression network analysis and support vector machine algorithm

通过整合加权基因共表达网络分析和支持向量机算法,鉴定出一种用于脓毒症患者的新型四基因诊断特征。

Li, Mingliang; Huang, He; Ke, Chunlian; Tan, Lei; Wu, Jiezhong; Xu, Shilei; Tu, Xusheng

Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9

十基因标记揭示骨肉瘤临床预后和免疫相关性的意义以及有关MMP9的新型骨骼抑制剂研究

Weihang Li, Ziyi Ding, Dong Wang, Chengfei Li, Yikai Pan, Yingjing Zhao, Hongzhe Zhao, Tianxing Lu, Rui Xu, Shilei Zhang, Bin Yuan, Yunlong Zhao, Yanjiang Yin, Yuan Gao, Jing Li, Ming Yan2

Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients

利用WGCNA和LASSO方法鉴定基于5个基因的评分系统以预测直肠癌患者的预后

Huang, He; Xu, Shilei; Chen, Aidong; Li, Fen; Wu, Jiezhong; Tu, Xusheng; Hu, Kunpeng

CITED4 enhances the metastatic potential of lung adenocarcinoma.

CITED4 增强肺腺癌的转移潜能

Zhang Lianmin, Wang Yuan, Sha Yongsheng, Zhang Bin, Zhang Rui, Zhang Hua, Xu Shilei, Wang Hailong, Xu Yue, Chen Yulong, Zhao Xiaoliang, Zhu Jianquan, Zhang Zhenfa, Wang Changli

Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials

氟唑帕尼可提高不携带 BRCA1/2 突变的非小细胞肺癌 (NSCLC) 细胞的放射敏感性,是一种正在进行临床试验的新型 PARP1 抑制剂。

Luo, Jing; Dai, Xinchi; Hu, Hua; Chen, Jie; Zhao, Lujun; Yang, Changyong; Sun, Jifeng; Zhang, Lianmin; Wang, Qian; Xu, Shilei; Xu, Yue; Liu, Ningbo; Ying, Guoguang; Wang, Ping

Propofol inhibits proliferation and epithelial-mesenchymal transition of MCF-7 cells by suppressing miR-21 expression

丙泊酚通过抑制 miR-21 表达抑制 MCF-7 细胞增殖和上皮-间质转化

Qing Du, Xuezhi Zhang, Xin Zhang, Ming Wei, Hongmei Xu, Shilei Wang

B-cell dynamics during experimental endotoxemia in humans

人类实验性内毒血症期间的 B 细胞动力学

Alexandra Brinkhoff, Ye Zeng, Annette Sieberichs, Sebastian Dolff, Xu Shilei, Ming Sun, Harald Engler, Sven Benson, Johannes Korth, Manfred Schedlowski, Andreas Kribben, Oliver Witzke, Benjamin Wilde

Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer

敲低长链非编码RNA linc-ITGB1可通过降低非小细胞肺癌中Snail的表达来抑制癌症干细胞特性和上皮-间质转化。

Guo, Lili; Sun, Cencen; Xu, Shilei; Xu, Yue; Dong, Qiuping; Zhang, Linlin; Li, Wei; Wang, Xingyu; Ying, Guoguang; Guo, Fengjie